References
- Garratty G. Immune hemolytic anemia associated with drug therapy. Blood Rev 2010;24:143–150.
- Darabi K, Kantamnei S, Wiernik PH. Lenalidomide-induced warm autoimmune hemolytic anemia. J Clin Oncol 2006;24:e59.
- Oren H, Ucar C, Gulen H, et al. Autoimmune hemolytic anemia occurring with myelodysplastic syndrome: report of a pediatric case and review of the literature. Ann Hematol 2001;80:540–542.
- List A, Kurtin S, Roe DJ, et al. Efficacy of lenalidomide in myelodysplastic syndromes. N Engl J Med 2005;352:549–557.
- Sun WL, Kock L, Walder A, et al. Successful treatment of MDS with lenalidomide, complicated by transient autoimmune hemolysis. Ann Hematol 2010;89:327–329.
- Brauer DL, Edelman B, Rapoport AP, et al. Plasma exchange and rituximab treatment for lenalidomide-associated cold agglutinin disease. Transfusion 2012;52:2432–2435.
- Montefusco V, Galli M, Spina F, et al. Autoimmune diseases during treatment with immunomodulatory drugs in multiple myeloma: selective occurrence after lenalidomide. Leuk Lymphoma 2014;55:2032–2037.
- Dimopoulos M, Spencer A, Attal M, et al. Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma. N Engl J Med 2007;357:2123–2132.
- Tamura H, Ogata K, Yokose N, et al. Autoimmune hemolytic anemia in patients with de novo acute myelocytic leukemia. Ann Hematol 1996;72:45–47.
- Kamesaki T, Toyotsuji T, Kajii E. Characterization of direct antiglobulin test-negative autoimmune hemolytic anemia:a study of 154 cases. Am J Hematol 2013;88:93–96.
- Zeidner JF, Foster MF. Immunomodulatry drugs: IMIDs in acute myeloid leukemia (AML). Special issue: Targets for immunotherapy in acute leukemia. Curr Drug Targets 2015; in press.
- Carver JR, Nasta S, Chong EA, et al. Myocarditis during lenalidomide therapy. Ann Pharmacother 2010;44:1840–1843.
- Dasanu CA, Alexandrescu DT. A case of severe aplastic anemia secondary to treatment with lenalidomide for multiple myeloma. Eur J Haematol 2009;82:231–234.
- Menon S, Habermann T, Witzig T. Lenalidomide-associated hypothyroidism. Leuk Lymphoma 2007;48:2465–2467.
- Deng A, Harvey V, Sina B, et al. Interstitial granulomatous dermatitis associated with the use of tumor necrosis factor alpha inhibitors. Arch Dermatol 2006;142:198–202.